These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 12655294)
1. Signaling and transcriptional control of Fas ligand gene expression. Kavurma MM; Khachigian LM Cell Death Differ; 2003 Jan; 10(1):36-44. PubMed ID: 12655294 [TBL] [Abstract][Full Text] [Related]
2. Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes. Ahn KS; Hahn BS; Kwack K; Lee EB; Kim YS Eur J Pharmacol; 2006 May; 537(1-3):1-11. PubMed ID: 16631160 [TBL] [Abstract][Full Text] [Related]
3. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells. Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589 [TBL] [Abstract][Full Text] [Related]
4. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908 [TBL] [Abstract][Full Text] [Related]
5. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826 [TBL] [Abstract][Full Text] [Related]
6. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. Matsui K; Fine A; Zhu B; Marshak-Rothstein A; Ju ST J Immunol; 1998 Oct; 161(7):3469-73. PubMed ID: 9759866 [TBL] [Abstract][Full Text] [Related]
7. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing. Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796 [TBL] [Abstract][Full Text] [Related]
9. Fas ligand, death gene. Pinkoski MJ; Green DR Cell Death Differ; 1999 Dec; 6(12):1174-81. PubMed ID: 10637433 [TBL] [Abstract][Full Text] [Related]
10. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Muppidi JR; Siegel RM Nat Immunol; 2004 Feb; 5(2):182-9. PubMed ID: 14745445 [TBL] [Abstract][Full Text] [Related]
11. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Huerta-Yepez S; Vega M; Garban H; Bonavida B Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892 [TBL] [Abstract][Full Text] [Related]
12. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells. Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441 [TBL] [Abstract][Full Text] [Related]
13. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling. Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204 [TBL] [Abstract][Full Text] [Related]
14. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756 [TBL] [Abstract][Full Text] [Related]
15. Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c-kit-expression in a Fas/FasL- and p53-independent manner. Choi YJ; Ok DW; Kwon DN; Chung JI; Kim HC; Yeo SM; Kim T; Seo HG; Kim JH FEBS Lett; 2004 Sep; 575(1-3):41-51. PubMed ID: 15388331 [TBL] [Abstract][Full Text] [Related]
16. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells. Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534 [TBL] [Abstract][Full Text] [Related]
17. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants. Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794 [TBL] [Abstract][Full Text] [Related]
18. The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy. Kim R; Emi M; Tanabe K; Uchida Y; Toge T Cancer; 2004 Jun; 100(11):2281-91. PubMed ID: 15160330 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis in human endometrium: apoptotic detection methods and signaling. Otsuki Y Med Electron Microsc; 2001 Sep; 34(3):166-73. PubMed ID: 11793192 [TBL] [Abstract][Full Text] [Related]
20. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW; Shah S Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]